.hidden: {display:none;}; .visible: {display:block;}; Washington, D.C. - FaegreBD Consulting
SEARCH

Washington, D.C. Office:

+1 202 312 7400 Main

+1 202 312 7461 Fax


1050 K Street NW, Suite 400

Washington, DC 20001

Contact:

David R. Zook [email protected] T:+1 202 589 2809

Related Services & Industries

Academic Medicine Coalition Management Economic Development Food & Agriculture Food Safety Management Public-Private Partnerships (P3) Strategic Communications Venture Philanthropy

Washington, D.C.

Press Releases

TitleDate
Kathleen Rice Appointed to U.S. Commission on Evidence-Based Policymaking 29 July 2016
Samantha Strong Brings Bioethics Background to FaegreBD Consulting 31 May 2016
Kelly Nickel Brings Diverse Background to Health & Biosciences Team 20 March 2016
Faegre Baker Daniels Promotes 8 Legal and Consulting Professionals 03 February 2016
National Defense Authorization Act Extension Represents Pro Bono Victory for FaegreBDC Client IRAP 01 December 2015

more press releases »

Published Articles

TitleDate
Internet Pharmacy Safeguards, We Salute You 11 May 2016
Regulators React to Debate Over Narrow Networks 02 May 2016
Several Factors Could Stand in the Way of the TPPA's Success 23 March 2016
Grains See Gains From TPP 08 March 2016
Broadband Challenges Remain for Rural Communities 20 January 2016

more published articles »

Media Mentions

TitleDate
Mike Adelberg Discusses Medicare Advantage Audits, Network Adequacy in Medicare Advantage News 15 July 2016
CMS Tackles Endorsements, Agent-Broker Compensation in New Marketing Guidance 27 June 2016
CMS Continues Data-Driven Approach to Optimizing Network Oversight 08 June 2016
Expect Changes to Risk Adjustment Oversight as CMS Feels Heat From GAO 31 May 2016
New CMS Rule Addresses Potential 'Gaming' of Special-Enrollment Period Loopholes 24 May 2016

more media mentions »

+1 202 312 7400 Main

+1 202 312 7461 Fax


1050 K Street NW, Suite 400

Washington, DC 20001

Contact:

David R. Zook
T:+1 202 589 2809
[email protected]

DISCLAIMER

Transmission of information to us via this feature does not establish a privileged relationship. Do not send any information that you would have treated confidentially.

Decline